Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus

Details for Australian Patent Application No. 2008268014 (hide)

Owner Japan Health Sciences Foundation

Inventors Kanda, Tadahito; Kondo, Kazunari

Agent Griffith Hack

Pub. Number AU-A-2008268014

PCT Pub. Number WO2009/001867

Priority 2007-167154 26.06.07 JP

Filing date 25 June 2008

Wipo publication date 31 December 2008

International Classifications

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/001867 Priority application(s): WO2009/001867

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008268056-An Improved Outboard Motor Mount

2008267947-A composition and method for pipeline conditioning and freezing point suppression